Average weight loss is one way to read a trial. Responder rate, the percentage of participants who actually crossed a clinically meaningful threshold, is often a more useful one.
In STEP 1, the responder thresholds were ≥5%, ≥10%, ≥15%, and ≥20% body-weight loss from baseline. These thresholds are the ones the trial reported.
In the semaglutide arm, 86.4% of participants reached ≥5% loss by week 68. About 69% reached ≥10%, 50% reached ≥15%, and 32% reached ≥20%. In the placebo arm, those numbers were 31.5%, 12.0%, 4.9%, and 1.7%.
Even taking the placebo arm into account, which captures the effect of the lifestyle counseling alone, the gap between groups is large at every threshold. The "responder rate" framing is what tells you that the average is not being dragged up by a small number of unusually large responders.
“The proportion of participants who lost at least 5% of their body weight at week 68 was 86.4% with semaglutide and 31.5% with placebo… More participants in the semaglutide group than in the placebo group achieved weight reductions of 10% or more, 15% or more, and 20% or more.”
Plain-English read
These are group-level figures from a structured trial of a branded medication, not a guarantee about any one person. Compounded formulations were not studied in this trial. Whether any medication is appropriate for you is decided by a licensed clinician.
Peer-reviewed source
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Wilding JPH, Batterham RL, Calanna S, et al. · New England Journal of Medicine, 2021 · DOI: 10.1056/NEJMoa2032183
Read the full study on NEJMThis article describes a clinical trial of a branded medication. The medications available through the TelePep store, and their prices, are listed on the programs page, and each is prescribed only if a licensed clinician decides it is appropriate.
This page is educational and is not medical advice. Trial results describe the FDA-approved products studied, not compounded formulations. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.